Discontinuation Cluster · Benzodiazepine
Klonopin (Clonazepam) Onsite Taper
Onsite clonazepam (Klonopin) taper — long half-life makes it the preferred cross-titration target — bridged with full-spectrum iboga TA.
Generic name
Clonazepam
Drug class
Benzodiazepine
Half-life class
long
Plasma half-life
≈ 30–40 hours
Typical dose range
0.5–4 mg/day
Onsite taper duration
21–45 days onsite
TA bridge
Iboga TA 50–150 mg BID (sub-psychoactive)
Quick Answer
Can I taper off Klonopin (Clonazepam) at MindScape?
Reviewed by Dr. Arellano, M.D. — May 2026
Withdrawal Profile
- Seizure risk on abrupt cessation
- Severe rebound anxiety and panic
- Insomnia, derealization
- Autonomic instability — tremor, sweating, BP swings
- Protracted withdrawal possible
Why It's Hard To Taper At Home
- Long half-life is a feature for stable plasma levels but means symptoms emerge slowly and are harder to attribute.
- Most outpatient prescribers won't manage tapers below 0.25 mg without compounded liquid.
- Protracted withdrawal can last months without supervised support.
MindScape Onsite Protocol
- Direct hyperbolic taper or cross-titration to diazepam if patient is also on a short-half-life benzo.
- Hyperbolic step-downs of 5–10% every 7–14 days using compounded liquid.
- Iboga TA bridge 50–150 mg BID for GABAergic coverage.
- Continuous cardiac telemetry with EEG at high-risk steps.
- Seizure-prophylactic magnesium and electrolyte normalization.
Day-By-Day Patient Experience
- Week 1: workup, magnesium loading, baseline EEG, first reduction.
- Weeks 2–5: hyperbolic step-downs with TA bridge.
- Weeks 6–7: full discontinuation under telemetry.
- Optional ibogaine HCl flood after washout and safety clearance.
Day-counts and step-cadences are illustrative ranges, not personal medical advice. Individual taper duration is determined onsite by the medical team after baseline workup.
Citations & Reading
- Ashton CH. (2002). The Ashton Manual.
- Lader M. (2011). Addiction, 106(12), 2086-2109.
For the broader iboga-TA evidence base, see the 2026 evidence-base review and the onsite taper cohort methodology page.